Dyad Medical
Software applications that support both treatment decision making in the clinic and analysis in research, enabling researchers to optimize observations and conclusions.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
$3.5m | Seed | ||
| Total Funding | 000k | ||
| USD | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Dyad Medical develops clinical applications using cloud-based artificial intelligence (AI) to enable doctors to interpret medical images more efficiently from anywhere in the world. The company's core focus is on cardiac imaging, addressing the significant global health issue of cardiovascular disease, which causes more deaths than cancer, diabetes, and accidents combined. Dyad Medical leverages the expertise of a global community of clinicians to train its AI models, providing practitioners with real-time, second opinions. The company operates within the digital diagnostics market, serving healthcare providers who require advanced imaging solutions to improve patient outcomes. Dyad Medical's business model involves offering subscription-based access to its AI-powered platform, generating revenue through recurring fees from healthcare institutions and professionals. By enhancing the accuracy and speed of medical image interpretation, Dyad Medical aims to improve diagnostic efficiency and patient care.
Keywords: AI, cloud-based, medical imaging, cardiac imaging, digital diagnostics, healthcare, clinicians, real-time, subscription-based, patient outcomes.